464 related articles for article (PubMed ID: 21557633)
1. Symptoms and signs of tear film dysfunction in glaucomatous patients.
Valente C; Iester M; Corsi E; Rolando M
J Ocul Pharmacol Ther; 2011 Jun; 27(3):281-5. PubMed ID: 21557633
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of ocular surface disease in glaucoma patients.
Leung EW; Medeiros FA; Weinreb RN
J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness.
Situ P; Simpson TL; Fonn D; Jones LW
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645
[TBL] [Abstract][Full Text] [Related]
4. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
[TBL] [Abstract][Full Text] [Related]
5. Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops.
Lajmi H; Chelly Z; Choura R; Mansour KB; Hmaied W
J Fr Ophtalmol; 2021 Nov; 44(9):1326-1331. PubMed ID: 34325926
[TBL] [Abstract][Full Text] [Related]
6. Effects of Prolonged Reading on Dry Eye.
Karakus S; Agrawal D; Hindman HB; Henrich C; Ramulu PY; Akpek EK
Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
[TBL] [Abstract][Full Text] [Related]
7. Tear film osmolarity in ocular mucous membrane pemphigoid.
Miserocchi E; Iuliano L; Berchicci L; Bandello F; Modorati G
Cornea; 2014 Jul; 33(7):668-72. PubMed ID: 24858022
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.
Yoon KC; Im SK; Kim HG; You IC
Cornea; 2011 Sep; 30(9):972-6. PubMed ID: 21705877
[TBL] [Abstract][Full Text] [Related]
9. [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension].
Van Went C; Alalwani H; Brasnu E; Pham J; Hamard P; Baudouin C; Labbé A
J Fr Ophtalmol; 2011 Dec; 34(10):684-90. PubMed ID: 22093372
[TBL] [Abstract][Full Text] [Related]
10. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.
Saade CE; Lari HB; Berezina TL; Fechtner RD; Khouri AS
Can J Ophthalmol; 2015 Apr; 50(2):132-6. PubMed ID: 25863853
[TBL] [Abstract][Full Text] [Related]
11. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.
Versura P; Profazio V; Giannaccare G; Fresina M; Campos EC
Eur J Ophthalmol; 2013; 23(4):488-95. PubMed ID: 23539457
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia.
Maychuk DY;
J Cataract Refract Surg; 2016 Mar; 42(3):427-34. PubMed ID: 27063524
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
15. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.
Liu X; Yu FF; Zhong YM; Guo XX; Mao Z
Chin Med J (Engl); 2015 Sep; 128(18):2444-9. PubMed ID: 26365960
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
[TBL] [Abstract][Full Text] [Related]
18. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
19. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals.
Ngo W; Srinivasan S; Houtman D; Jones L
J Optom; 2017; 10(1):26-33. PubMed ID: 27425263
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface disease and glaucoma: how to evaluate impact on quality of life.
Rossi GC; Pasinetti GM; Scudeller L; Bianchi PE
J Ocul Pharmacol Ther; 2013 May; 29(4):390-4. PubMed ID: 23215770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
